Medical cannabis campaigner Robin Emerson has launched his own distribution company, Elite Pharmaco.
Emerson became a high profile advocate for patient access after after his daughter Jorja’s struggle to get treatment for severe epilepsy.
Now he’s going into business with cannabis executive Liam McGreevy to set up his own firm which will bring products to the UK, Ireland and Europe.
Emerson, who credits medical cannabis with saving his daughter’s life, said: “For cannabis to remain a dynamic growth industry, it must offer more products, processes and solutions that are clinically validated, safe, sustainable and cost-effective so more patients can benefit from this transformative plant.
“Our purpose is to meet the needs of the medical cannabis market by providing the best products, expert services and consulting to exceed expectations at all times to suppliers, partners and patients.
“This will ensure we have a seamless experience for patients in the UK and in Europe.”
As well as brining existing treatments to market, the company will also launch clinical trials for new drugs to treat a range of conditions.
McGreevy boasts more than a decade’s worth of experience in the industry and is the ‘founder and director of several high-profile cannabis industry businesses’.
McGreevy said: “This is a multifaceted emerging market, characterised by growers at one end to distributors of products at the other.
“As the industry heads towards increased regulation, reaping the benefits of the European medical cannabis market requires a strong and sustainable business strategy sustained by robust and trusted support. At Elite, we bring those qualities and more.”
Elite Pharmaco has already signed a strategic distribution and clinical consulting agreement with MGC Pharmaceuticals, the first cannabis company to list on the London Stock Exchange.
Ron Lipsky of MGC Pharmaceuticals said: “The distributor in every country is crucial to ensuring consistent and effective delivery of the medicines we make to the patients.
“Our choice is always to find distributors with an innate understanding of their local regulations and pathways.
“Given Elite’s personal background and continued commitment to patient access and advocacy, MGC sees the relationship as a significant element of our UK strategy.”